| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.007 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.22 | 0.008 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.008 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.4 | 0.008 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.31 | 0.009 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.17 | 0.009 |